Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > Plant-based diets cut risk of prostate cancer progression and recurrence by over 50%
  • News

Plant-based diets cut risk of prostate cancer progression and recurrence by over 50%

  • 9 March 2023
  • Janet Fricker
Plant-based diets cut risk of prostate cancer progression and recurrence by over 50%
Total
0
Shares
0
0
0
0
0

Prostate cancer patients who consume the highest intakes of plant-based foods lower their risk of progression and recurrence. The study, abstract 392 presented at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium, held in San Francisco, February 16–18, found that men with prostate cancer who reported the highest intakes of plant-based foods had a 52% lower risk of progression and 53% lower risk of recurrence in comparison to those with the lowest intakes.

“We’ve known that diets that include vegetables, fruits, legumes, and whole grains are associated with numerous health benefits, including a reduction in diabetes, cardiovascular disease, and overall mortality. We can now add benefits in reducing prostate cancer progression to that list,” says Vivian Liu, the lead author from Osher Center for Integrative Health, University of California, San Francisco.

While observational studies have reported that plant foods, such as tomatoes (containing lycopene) and cruciferous vegetables (eg cauliflower, broccoli), appear to reduce prostate cancer incidence and mortality, less is known about plant-based dietary patterns and prostate cancer survivorship. To the investigators’ knowledge, the current study is the first to evaluate plant-based dietary patterns among survivors of prostate cancer.

For the current study, 2,038 men diagnosed with T1–3a stage (with no spread of disease or limited spread), who were enrolled in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) study, completed a food frequency questionnaire at a median of 31.5 months post-diagnosis. Diet indices were then scored according to the healthful plant-based diet index (hPDI) with composite sums of positive or negative values assigned to plant-based or animal-based food groups in the diet.

To prevent bias, investigators adjusted for factors including days since diagnosis until the first questionnaire was given, age at diagnosis, year diagnosed, total energy intake, CaPSURE clinical site, race, walking pace, smoking status, Gleason risk score at diagnosis, prostate-specific antigen (PSA) level at diagnosis, and primary treatment.

Results showed 10% of participants (n=204) experienced progression over a median of 7.4 years of observation. Men in the highest quintile of the hPDI had a lower risk for progression in comparison to those in the lowest quintile (HR 0.48; P-trend <0.001) and a lower risk for recurrence (HR 0.47; P-trend <0.001) in comparison to those in the lowest quintile. In a subgroup analysis of men older than 65 years, the highest hPDI consumption was associated with an even lower risk of recurrence (HR 0.41; P-trend=0.03).

Limitations of the study included the fact that it did not adjust for pre-diagnostic diets (men in the cohort had already been diagnosed with prostate cancer), and that it did not take into account factors such as genetics and metabolism.

“One of the major concerns for patients, families, caregivers, and physicians is progression of prostate cancer to advanced stages. These findings are significant in informing clinical care, such as providing dietary recommendations to manage health and reduce morbidity caused by this common cancer affecting men. Moreover, adopting a plant-based diet may also reduce the risk of other chronic diseases (eg, diabetes, cardiovascular disease) and overall mortality, thereby promoting overall health and well-being,” Liu told Cancerworld.

Next, the team plan to conduct analyses looking at post-diagnostic plant-based diets in relation to prostate cancer-specific mortality. They also plan to examine the plant-based dietary indices in relation to prostate-cancer-specific quality of life at two, five, and 10 years from baseline.

“Prostate cancer treatment can lead to adverse side effects, including sexual and urinary problems and poorer physical and mental health. We hypothesise that plant-based diets could directly affect quality of life symptoms… in men with prostate cancer,” says Liu.

A similar picture for the benefit of plant-based diets, the team believe, is likely to hold in other cancers.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • diet
  • healthful plant based index
  • plan- based diets
  • prostate cancer
  • prostate cancer progression
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • Articles
  • Delivery of Care

Food insecurity: Why screening for access to nutrition should be part of cancer treatment everywhere

  • 24 February 2023
  • Swagata Yadavar
View Post
Next Article
  • News

Radiotherapy can be safely omitted in older women with low-risk breast cancer

  • 10 March 2023
  • Janet Fricker
View Post
You May Also Like
View Post
  • News

Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study

  • Yeva Margaryan
  • 8 May 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in April: Oncology’s Top Moments

  • Yeva Margaryan
  • 7 May 2025
View Post
  • News

CancerWorld #102 (April 2025)

  • Yeva Margaryan
  • 22 April 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in March: Oncology’s Top Moments

  • Yeva Margaryan
  • 8 April 2025
View Post
  • News

Ovarian cancer: mechanism conferring resistance to immunotherapy revealed

  • Janet Fricker
  • 21 March 2025
View Post
  • News

Muscular strength and cardiorespiratory fitness improve survival in cancer patients

  • Janet Fricker
  • 20 March 2025
View Post
  • News

CancerWorld #101 (February 2025): The Must-Read Oncology Issue Returns to Print with Exclusive Interviews and Breakthroughs

  • Yeva Margaryan
  • 18 March 2025
View Post
  • News

Low-dose aspirin reduces colorectal cancer recurrence in patients with PI3K alterations

  • Janet Fricker
  • 6 March 2025
search
CancerWorld #101 Download CancerWorld #101 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study
    • 8 May 2025
  • What Caught Our Eye in April: Oncology’s Top Moments
    • 7 May 2025
  • CancerWorld #102 (April 2025)
    • 22 April 2025
  • What Caught Our Eye in March: Oncology’s Top Moments
    • 8 April 2025
  • Ovarian cancer: mechanism conferring resistance to immunotherapy revealed
    • 21 March 2025
Article
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • Istanbul, Ankara take action on HPV vaccination, as government delays promised national programme
    • 1 April 2025
  • Could this dual approach be the frontier that finally gets immunotherapy to work for MSS colorectal cancer?
    • 31 March 2025
Social

Would you follow us ?

Contents
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • “I really care about people.” – Philip Kantoff, A Life in Science and Medicine
    • 5 May 2025
  • What If the World’s Leading Prostate Cancer Epidemiologist Opened a Restaurant? A Conversation with Lorelei Mucci- A Harvard Scientist, A Mother, A Leader
    • 23 April 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.